APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Tumor Chinese Medicine Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Tumor Chinese Medicine Injection Industry Growth and Trends Forecast to 2032

23 December 202592 pages

Choose your research edition.

Industry ResearchAnti-Tumor Chinese Medicine Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Tumor Chinese Medicine Injection Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Anti-Tumor Chinese Medicine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Tumor Chinese Medicine Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Tumor Chinese Medicine Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Anti-Tumor Chinese Medicine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Tumor Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Tumor Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Tumor Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Tumor Chinese Medicine Injection include Guizhou Yibai Pharmaceutical, Zhendong Health Industry Group, Livzon, Jemincare and CR Sanjiu, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Tumor Chinese Medicine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Tumor Chinese Medicine Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Tumor Chinese Medicine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Tumor Chinese Medicine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Tumor Chinese Medicine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Tumor Chinese Medicine Injection Market by Company

Guizhou Yibai Pharmaceutical

Zhendong Health Industry Group

Livzon

Jemincare

CR Sanjiu

Anti-Tumor Chinese Medicine Injection Segment by Type

Kanglaite Injection

Huachan Injection

Fufang Kushen Injection

Shenqi Fuzheng Injection

Aidi Injection

Anti-Tumor Chinese Medicine Injection Segment by Application

Hospital

Clinic

Anti-Tumor Chinese Medicine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Tumor Chinese Medicine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Tumor Chinese Medicine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Tumor Chinese Medicine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Tumor Chinese Medicine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Tumor Chinese Medicine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Kanglaite Injection Table 2. Major Company of Huachan Injection Table 3. Major Company of Fufang Kushen Injection Table 4. Major Company of Shenqi Fuzheng Injection Table 5. Major Company of Aidi Injection Table 6. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (k units) Table 8. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Type (2021-2026) Table 9. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (US$ Million) Table 10. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Type (2021-2026) Table 11. Global Anti-Tumor Chinese Medicine Injection Price by Type (2021-2026) & (USD/unit) Table 12. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2027-2032) & (k units) Table 13. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Type (2027-2032) Table 14. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2027-2032) & (US$ Million) Table 15. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Type (2027-2032) Table 16. Global Anti-Tumor Chinese Medicine Injection Price by Type (2027-2032) & (USD/unit) Table 17. North America Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (k units) Table 18. North America Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (k units) Table 20. Europe Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (k units) Table 24. Latin America Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (US$ Million) Table 27. Anti-Tumor Chinese Medicine Injection Industry Trends Table 28. Anti-Tumor Chinese Medicine Injection Industry Drivers Table 29. Anti-Tumor Chinese Medicine Injection Industry Opportunities and Challenges Table 30. Anti-Tumor Chinese Medicine Injection Industry Restraints Table 31. Global Anti-Tumor Chinese Medicine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Company (2021-2026) Table 33. Global Anti-Tumor Chinese Medicine Injection Sales by Company (2021-2026) & (k units) Table 34. Global Anti-Tumor Chinese Medicine Injection Sales Share by Company (2021-2026) Table 35. Global Anti-Tumor Chinese Medicine Injection Market Price by Company (2021-2026) & (USD/unit) Table 36. Global Anti-Tumor Chinese Medicine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Anti-Tumor Chinese Medicine Injection Major Company Production Sites and Headquarters Table 38. Global Anti-Tumor Chinese Medicine Injection Company, Product Type & Application Table 39. Global Anti-Tumor Chinese Medicine Injection Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Anti-Tumor Chinese Medicine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Anti-Tumor Chinese Medicine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Anti-Tumor Chinese Medicine Injection Sales by Region (2021-2026) & (k units) Table 44. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Region (2021-2026) Table 45. Global Anti-Tumor Chinese Medicine Injection Sales by Region (2021-2026) & (US$ Million) Table 46. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Region (2021-2026) Table 47. Global Anti-Tumor Chinese Medicine Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 48. Global Anti-Tumor Chinese Medicine Injection Sales by Region (2027-2032) & (k units) Table 49. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Region (2027-2032) Table 50. Global Anti-Tumor Chinese Medicine Injection Sales by Region (2027-2032) & (US$ Million) Table 51. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Region (2027-2032) Table 52. Global Anti-Tumor Chinese Medicine Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 53. Global Anti-Tumor Chinese Medicine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (k units) Table 55. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Application (2021-2026) Table 56. Global Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (US$ Million) Table 57. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Application (2021-2026) Table 58. Global Anti-Tumor Chinese Medicine Injection Price by Application (2021-2026) & (USD/unit) Table 59. Global Anti-Tumor Chinese Medicine Injection Sales by Application (2027-2032) & (k units) Table 60. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Application (2027-2032) Table 61. Global Anti-Tumor Chinese Medicine Injection Sales by Application (2027-2032) & (US$ Million) Table 62. Global Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Application (2027-2032) Table 63. Global Anti-Tumor Chinese Medicine Injection Price by Application (2027-2032) & (USD/unit) Table 64. North America Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (k units) Table 65. North America Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (k units) Table 67. Europe Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (k units) Table 71. Latin America Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (US$ Million) Table 74. Guizhou Yibai Pharmaceutical Company Information Table 75. Guizhou Yibai Pharmaceutical Business Overview Table 76. Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Product Portfolio Table 78. Guizhou Yibai Pharmaceutical Recent Development Table 79. Zhendong Health Industry Group Company Information Table 80. Zhendong Health Industry Group Business Overview Table 81. Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Product Portfolio Table 83. Zhendong Health Industry Group Recent Development Table 84. Livzon Company Information Table 85. Livzon Business Overview Table 86. Livzon Anti-Tumor Chinese Medicine Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Livzon Anti-Tumor Chinese Medicine Injection Product Portfolio Table 88. Livzon Recent Development Table 89. Jemincare Company Information Table 90. Jemincare Business Overview Table 91. Jemincare Anti-Tumor Chinese Medicine Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Jemincare Anti-Tumor Chinese Medicine Injection Product Portfolio Table 93. Jemincare Recent Development Table 94. CR Sanjiu Company Information Table 95. CR Sanjiu Business Overview Table 96. CR Sanjiu Anti-Tumor Chinese Medicine Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. CR Sanjiu Anti-Tumor Chinese Medicine Injection Product Portfolio Table 98. CR Sanjiu Recent Development Table 99. North America Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 100. North America Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (k units) Table 101. North America Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026) Table 102. North America Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (k units) Table 103. North America Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Country (2027-2032) Table 104. North America Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Anti-Tumor Chinese Medicine Injection Market Share by Country (2021-2026) Table 107. North America Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Anti-Tumor Chinese Medicine Injection Market Share Forecast by Country (2027-2032) Table 109. Europe Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 110. Europe Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (k units) Table 111. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026) Table 112. Europe Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (k units) Table 113. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Anti-Tumor Chinese Medicine Injection Market Share by Country (2021-2026) Table 117. Europe Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Anti-Tumor Chinese Medicine Injection Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (k units) Table 121. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (k units) Table 123. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Share by Country (2021-2026) Table 127. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Share Forecast by Country (2027-2032) Table 129. Latin America Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Latin America Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (k units) Table 131. Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026) Table 132. Latin America Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (k units) Table 133. Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Anti-Tumor Chinese Medicine Injection Market Share by Country (2021-2026) Table 137. Latin America Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Anti-Tumor Chinese Medicine Injection Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (k units) Table 141. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (k units) Table 143. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Share by Country (2021-2026) Table 147. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Anti-Tumor Chinese Medicine Injection Distributors List Table 152. Anti-Tumor Chinese Medicine Injection Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Anti-Tumor Chinese Medicine Injection Image Figure 2. Global Anti-Tumor Chinese Medicine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Tumor Chinese Medicine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Tumor Chinese Medicine Injection Sales (2021-2032) & (k units) Figure 5. Kanglaite Injection Image Figure 6. Global Kanglaite Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. Huachan Injection Image Figure 8. Global Huachan Injection Sales YoY Growth (2021-2032) & (k units) Figure 9. Fufang Kushen Injection Image Figure 10. Global Fufang Kushen Injection Sales YoY Growth (2021-2032) & (k units) Figure 11. Shenqi Fuzheng Injection Image Figure 12. Global Shenqi Fuzheng Injection Sales YoY Growth (2021-2032) & (k units) Figure 13. Aidi Injection Image Figure 14. Global Aidi Injection Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Anti-Tumor Chinese Medicine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Anti-Tumor Chinese Medicine Injection Market Share by Type 2025 VS 2032 Figure 17. North America Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Type in 2025 Figure 18. North America Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Type in 2025 Figure 19. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Type in 2025 Figure 23. Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Anti-Tumor Chinese Medicine Injection Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Anti-Tumor Chinese Medicine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anti-Tumor Chinese Medicine Injection Market Share by Application 2025 VS 2032 Figure 35. North America Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Anti-Tumor Chinese Medicine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Anti-Tumor Chinese Medicine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anti-Tumor Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anti-Tumor Chinese Medicine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-Tumor Chinese Medicine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Anti-Tumor Chinese Medicine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-Tumor Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anti-Tumor Chinese Medicine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-Tumor Chinese Medicine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Anti-Tumor Chinese Medicine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-Tumor Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anti-Tumor Chinese Medicine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-Tumor Chinese Medicine Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anti-Tumor Chinese Medicine Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Kanglaite Injection
  • Huachan Injection
  • Fufang Kushen Injection
  • Shenqi Fuzheng Injection
  • Aidi Injection
Applications
  • Hospital
  • Clinic
Companies covered
  • Guizhou Yibai Pharmaceutical
  • Zhendong Health Industry Group
  • Livzon
  • Jemincare
  • CR Sanjiu

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Tumor Chinese Medicine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Tumor Chinese Medicine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Tumor Chinese Medicine Injection Market by Type
  6. 1.3.1 Kanglaite Injection
  7. 1.3.2 Huachan Injection
  8. 1.3.3 Fufang Kushen Injection
  9. 1.3.4 Shenqi Fuzheng Injection
  10. 1.3.5 Aidi Injection
  11. 1.4 Global Anti-Tumor Chinese Medicine Injection Market Size by Type
  12. 1.4.1 Global Anti-Tumor Chinese Medicine Injection Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Anti-Tumor Chinese Medicine Injection Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Anti-Tumor Chinese Medicine Injection Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Anti-Tumor Chinese Medicine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Anti-Tumor Chinese Medicine Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Anti-Tumor Chinese Medicine Injection Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Tumor Chinese Medicine Injection Industry Trends
  2. 2.2 Anti-Tumor Chinese Medicine Injection Industry Drivers
  3. 2.3 Anti-Tumor Chinese Medicine Injection Industry Opportunities and Challenges
  4. 2.4 Anti-Tumor Chinese Medicine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Tumor Chinese Medicine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Tumor Chinese Medicine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Tumor Chinese Medicine Injection Price (2021-2026)
  4. 3.4 Global Anti-Tumor Chinese Medicine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Tumor Chinese Medicine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Tumor Chinese Medicine Injection Company, Product Type & Application
  7. 3.7 Global Anti-Tumor Chinese Medicine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Tumor Chinese Medicine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Tumor Chinese Medicine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Tumor Chinese Medicine Injection Tier 1, Tier 2, and Tier 3
4 Anti-Tumor Chinese Medicine Injection Regional Status and Outlook
  1. 4.1 Global Anti-Tumor Chinese Medicine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Tumor Chinese Medicine Injection Historic Market Size by Region
  3. 4.2.1 Global Anti-Tumor Chinese Medicine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Tumor Chinese Medicine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Tumor Chinese Medicine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Tumor Chinese Medicine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Tumor Chinese Medicine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Tumor Chinese Medicine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Tumor Chinese Medicine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Tumor Chinese Medicine Injection by Application
  1. 5.1 Anti-Tumor Chinese Medicine Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Anti-Tumor Chinese Medicine Injection Market Size by Application
  5. 5.2.1 Global Anti-Tumor Chinese Medicine Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti-Tumor Chinese Medicine Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti-Tumor Chinese Medicine Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti-Tumor Chinese Medicine Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti-Tumor Chinese Medicine Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti-Tumor Chinese Medicine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Guizhou Yibai Pharmaceutical
  2. 6.1.1 Guizhou Yibai Pharmaceutical Company Information
  3. 6.1.2 Guizhou Yibai Pharmaceutical Business Overview
  4. 6.1.3 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Product Portfolio
  6. 6.1.5 Guizhou Yibai Pharmaceutical Recent Developments
  7. 6.2 Zhendong Health Industry Group
  8. 6.2.1 Zhendong Health Industry Group Company Information
  9. 6.2.2 Zhendong Health Industry Group Business Overview
  10. 6.2.3 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Product Portfolio
  12. 6.2.5 Zhendong Health Industry Group Recent Developments
  13. 6.3 Livzon
  14. 6.3.1 Livzon Company Information
  15. 6.3.2 Livzon Business Overview
  16. 6.3.3 Livzon Anti-Tumor Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Livzon Anti-Tumor Chinese Medicine Injection Product Portfolio
  18. 6.3.5 Livzon Recent Developments
  19. 6.4 Jemincare
  20. 6.4.1 Jemincare Company Information
  21. 6.4.2 Jemincare Business Overview
  22. 6.4.3 Jemincare Anti-Tumor Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jemincare Anti-Tumor Chinese Medicine Injection Product Portfolio
  24. 6.4.5 Jemincare Recent Developments
  25. 6.5 CR Sanjiu
  26. 6.5.1 CR Sanjiu Company Information
  27. 6.5.2 CR Sanjiu Business Overview
  28. 6.5.3 CR Sanjiu Anti-Tumor Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CR Sanjiu Anti-Tumor Chinese Medicine Injection Product Portfolio
  30. 6.5.5 CR Sanjiu Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Tumor Chinese Medicine Injection Sales by Country
  2. 7.1.1 North America Anti-Tumor Chinese Medicine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Tumor Chinese Medicine Injection Market Size by Country
  6. 7.2.1 North America Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Tumor Chinese Medicine Injection Sales by Country
  2. 8.1.1 Europe Anti-Tumor Chinese Medicine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Tumor Chinese Medicine Injection Market Size by Country
  6. 8.2.1 Europe Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Tumor Chinese Medicine Injection Sales by Country
  2. 10.1.1 South America Anti-Tumor Chinese Medicine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Tumor Chinese Medicine Injection Market Size by Country
  6. 10.2.1 South America Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Tumor Chinese Medicine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Tumor Chinese Medicine Injection Value Chain Analysis
  2. 12.1.1 Anti-Tumor Chinese Medicine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Tumor Chinese Medicine Injection Production Mode & Process
  7. 12.2 Anti-Tumor Chinese Medicine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Tumor Chinese Medicine Injection Distributors
  10. 12.2.3 Anti-Tumor Chinese Medicine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst